SCHEMBL13848619

SCHEMBL13848619

CN(C)c1ccc2c(-c3ccccc3C(=O)O)c3ccc(=N)cc-3oc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.58
USP2 O75604 5/20 0.56
ATM Q13315 2/20 0.56
CFTR P13569 1/20 0.56
PAX8 Q06710 1/20 0.56
GOPC Q9HD26 1/20 0.56
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
THRB P10828 2/20 0.52
RECQL P46063 2/20 0.52
BLM P54132 2/20 0.52
TDP1 Q9NUW8 2/20 0.52
P2RY6 Q15077 1/20 0.44
FTO Q9C0B1 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.42
POLB P06746 3/20 0.42
KDM4E B2RXH2 2/20 0.42
CYP3A4 P08684 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13179036 0.89 ABCB1 (0.56) ABCB1USP2ATMCFTRPAX8
SCHEMBL92964 0.88 P2RY6 (0.49) ABCB1USP2ATMCFTRPAX8
SCHEMBL14942851 0.88 ABCB1 (0.48) ABCB1USP2ATMCFTRPAX8
SCHEMBL14640186 0.87 MEN1 (0.44) ABCB1USP2ATMCFTRPAX8
Tetramethylrhodamine SCHEMBL2054818 0.86 MEN1 (0.71) ABCB1USP2ATMCFTRPAX8
SCHEMBL13805717 0.86 MEN1 (0.46) ABCB1USP2ATMCFTRPAX8
SCHEMBL13966918 0.86 ABCB1 (0.61) ABCB1USP2ATMCFTRPAX8
SCHEMBL14959448 0.85 MEN1 (0.50) ABCB1USP2ATMCFTRPAX8
SCHEMBL19520078 0.85 MEN1 (0.50) ABCB1USP2ATMCFTRPAX8
SCHEMBL13078711 0.85 ABCB1 (0.49) ABCB1USP2ATMCFTRPAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130190335-A1 FLUORESCENT ANTAGONISTS OF THE A3 ADENOSINE RECEPTOR The United State of America, as represented by the Secretary, Department of Health and Human Service (US) 2013-07-25 US disclosed
EP-1212457-B1 UV EXCITABLE FLUORESCENT ENERGY TRANSFER DYES APPLIED BIOSYSTEMS LLC (US) 2009-05-06 EP disclosed
US-7402671-B2 UV excitable fluorescent energy transfer dyes APPLERA CORPORATION (US) 2008-07-22 US disclosed
US-7157572-B2 UV excitable energy transfer reagents APPLERA CORPORATION (US) 2007-01-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130190335-A1 FLUORESCENT ANTAGONISTS OF THE A3 ADENOSINE RECEPTOR ADORA3, ADORA2A, ADORA1 ABCB1 95/4885USP2 4587/4885ATM 3551/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.